Landec Corporation Sets Fourth Quarter and Fiscal Year-End 2016 Conference Call for July 27, 2016 at 8 a.m. PT and Earnings Release set for July 26, 2016 After Market


MENLO PARK, Calif., July 06, 2016 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq:LNDC) will hold a conference call on Wednesday, July 27, 2016 at 8 a.m. Pacific time to discuss its results for the fiscal fourth quarter and fiscal year-end 2016. Financial results will be reported for the 2016 fiscal fourth quarter and fiscal year ended May 29, 2016 after market close on July 26, 2016.

Landec's President and CEO, Molly Hemmeter, will host the Conference Call with Gregory S. Skinner, Vice President and CFO. A question and answer period will follow the presentation.

Date: Wednesday, July 27, 2016
Time: 8 a.m. Pacific time (11 a.m. Eastern time)  
Toll Free Participant Dial-in Number: (866) 814-1914
U.S. and International Toll Number: (703) 639-1358
Conference ID: 1674080

Webcast:  www.Landec.com/earningscall
The webcast will be available for 30 days through August 26, 2016.

A replay of the teleconference will be available for one week until midnight Eastern Time, Wednesday, August 3, 2016.

Toll free replay dial in: 888-266-2081
International replay:  703-925-2533 
Replay passcode: 1674080

About Landec Corporation

Landec Corporation is a company that leverages its proprietary polymer technologies, application development and innovation capabilities to develop and commercialize new products in food and biomaterials markets. Landec’s subsidiary, Apio, has become the leader in U.S. fresh-cut specialty packaged vegetables sold in North America based on combining Landec’s BreatheWay® proprietary food packaging technology with the capabilities of large scale processing and national distribution. Lifecore Biomedical, a subsidiary of Landec, is a premium supplier of hyaluronan-based materials and medical products to ophthalmic, orthopedic and veterinary markets worldwide. In addition, Lifecore Biomedical provides specialized aseptic fill and finish services in a cGMP (current good manufacturing practices) validated manufacturing facility for supplying commercial, clinical and pre-clinical products. Landec will also periodically work with market-leading companies to develop and commercialize differentiated polymer-based products under R&D and royalty agreements.  For more information about the company, visit Landec’s website at www.landec.com.


            

Contact Data